Acrux (ACR.AX) Stock Price

Acrux Price

ASX·CLOSED
0.01AUD+0.00 (+0.00 %)
Market closed

Over the last 19 years Acrux grew revenue by 2.6% annually, reaching 4.53 M AUD. Earnings per share have declined at 19.5% per year over the last 6 years. For Acrux, the net margin of -131.3% is up versus -263.5% a few years ago. At today's price the dividend yield works out to roughly 745.34%. The payout ratio is around 155% of earnings. The stock trades about 28% above its 52-week low.

Acrux stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Acrux over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Acrux stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Acrux's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Acrux Stock Price History
DateAcrux Price
7/10/20260.01 AUD
7/9/20260.01 AUD
7/8/20260.01 AUD
7/7/20260.01 AUD
7/6/20260.01 AUD
7/3/20260.01 AUD
7/2/20260.01 AUD
7/1/20260.01 AUD
6/30/20260.01 AUD
6/29/20260.01 AUD
6/26/20260.01 AUD
6/25/20260.01 AUD
6/24/20260.01 AUD
6/23/20260.01 AUD
6/22/20260.01 AUD
6/19/20260.01 AUD
6/18/20260.01 AUD
6/17/20260.01 AUD
6/16/20260.02 AUD
6/15/20260.02 AUD
6/12/20260.02 AUD
6/11/20260.02 AUD
6/10/20260.02 AUD
6/9/20260.01 AUD
6/5/20260.01 AUD
6/4/20260.01 AUD
6/3/20260.01 AUD
6/2/20260.01 AUD
6/1/20260.01 AUD
5/29/20260.01 AUD
5/28/20260.01 AUD
5/27/20260.01 AUD
5/26/20260.01 AUD
5/25/20260.01 AUD
5/22/20260.01 AUD
5/21/20260.01 AUD
5/20/20260.01 AUD
5/19/20260.01 AUD
5/18/20260.01 AUD
5/15/20260.01 AUD
5/14/20260.01 AUD
5/13/20260.01 AUD
5/12/20260.01 AUD
5/11/20260.01 AUD
5/8/20260.01 AUD
5/7/20260.01 AUD
5/6/20260.01 AUD
5/5/20260.01 AUD
5/4/20260.01 AUD
5/1/20260.01 AUD
4/30/20260.01 AUD
4/29/20260.01 AUD
4/28/20260.01 AUD
4/27/20260.01 AUD
4/24/20260.01 AUD
4/23/20260.01 AUD
4/22/20260.01 AUD
4/21/20260.01 AUD
4/20/20260.01 AUD
4/17/20260.01 AUD
4/16/20260.01 AUD
4/15/20260.01 AUD
4/14/20260.01 AUD
4/13/20260.01 AUD
4/10/20260.01 AUD
4/9/20260.01 AUD
4/8/20260.01 AUD
4/7/20260.01 AUD
4/2/20260.01 AUD
4/1/20260.01 AUD
3/31/20260.01 AUD
3/30/20260.01 AUD
3/27/20260.01 AUD
3/26/20260.01 AUD
3/25/20260.01 AUD
3/24/20260.01 AUD
3/23/20260.01 AUD
3/20/20260.01 AUD
3/19/20260.01 AUD
3/18/20260.01 AUD
3/17/20260.01 AUD
3/16/20260.01 AUD
3/13/20260.01 AUD
3/12/20260.01 AUD
3/11/20260.01 AUD
3/10/20260.01 AUD
3/9/20260.01 AUD
3/6/20260.01 AUD
3/5/20260.01 AUD
3/4/20260.01 AUD
3/3/20260.01 AUD
3/2/20260.01 AUD
2/27/20260.01 AUD
2/26/20260.01 AUD
2/25/20260.01 AUD
2/24/20260.01 AUD
2/23/20260.01 AUD
2/20/20260.01 AUD
2/19/20260.01 AUD
2/18/20260.01 AUD
2/17/20260.01 AUD
2/16/20260.01 AUD
2/13/20260.01 AUD
2/12/20260.01 AUD
2/11/20260.01 AUD
2/10/20260.01 AUD
2/9/20260.01 AUD
2/6/20260.01 AUD
2/5/20260.02 AUD
2/4/20260.01 AUD
2/3/20260.01 AUD
2/2/20260.01 AUD
1/30/20260.01 AUD
1/29/20260.01 AUD
1/28/20260.01 AUD
1/27/20260.01 AUD
1/23/20260.01 AUD
1/22/20260.01 AUD
1/21/20260.01 AUD
1/20/20260.01 AUD
1/19/20260.01 AUD
1/16/20260.01 AUD
1/15/20260.01 AUD
1/14/20260.01 AUD
1/13/20260.01 AUD
1/12/20260.01 AUD
1/9/20260.01 AUD
1/8/20260.01 AUD
1/7/20260.02 AUD
1/6/20260.01 AUD
1/5/20260.01 AUD
1/2/20260.01 AUD
12/31/20250.01 AUD
12/30/20250.01 AUD
12/29/20250.01 AUD
12/24/20250.01 AUD
12/23/20250.01 AUD
12/22/20250.01 AUD
12/19/20250.01 AUD
12/18/20250.01 AUD
12/17/20250.01 AUD
12/16/20250.02 AUD
12/15/20250.02 AUD
12/12/20250.02 AUD
12/11/20250.02 AUD
12/10/20250.02 AUD
12/9/20250.02 AUD
12/8/20250.02 AUD
12/5/20250.02 AUD
12/4/20250.02 AUD
12/3/20250.02 AUD
12/2/20250.01 AUD
12/1/20250.01 AUD
11/28/20250.01 AUD
11/27/20250.01 AUD
11/26/20250.02 AUD
11/25/20250.02 AUD
11/24/20250.01 AUD
11/21/20250.02 AUD
11/20/20250.01 AUD
11/19/20250.01 AUD
11/18/20250.02 AUD
11/17/20250.02 AUD
11/14/20250.01 AUD
11/13/20250.01 AUD
11/12/20250.02 AUD
11/11/20250.02 AUD
11/10/20250.02 AUD
11/7/20250.02 AUD
11/6/20250.01 AUD
11/5/20250.01 AUD
11/4/20250.01 AUD
11/3/20250.01 AUD
10/31/20250.01 AUD
10/30/20250.01 AUD
10/29/20250.01 AUD
10/28/20250.01 AUD
10/27/20250.01 AUD
10/24/20250.01 AUD
10/23/20250.01 AUD
10/22/20250.01 AUD
10/21/20250.01 AUD
10/20/20250.01 AUD
10/17/20250.01 AUD
10/16/20250.01 AUD
10/15/20250.01 AUD
10/14/20250.01 AUD
10/13/20250.01 AUD
10/10/20250.01 AUD
10/9/20250.01 AUD
10/8/20250.01 AUD
10/7/20250.01 AUD
10/6/20250.01 AUD
10/3/20250.01 AUD
10/2/20250.01 AUD
10/1/20250.01 AUD
9/30/20250.01 AUD
9/29/20250.01 AUD
9/26/20250.01 AUD
9/25/20250.01 AUD
9/24/20250.01 AUD
9/23/20250.01 AUD
9/22/20250.01 AUD
9/19/20250.01 AUD
9/18/20250.01 AUD
9/17/20250.01 AUD
9/16/20250.01 AUD
9/15/20250.01 AUD
9/12/20250.01 AUD
9/11/20250.01 AUD
9/10/20250.01 AUD
9/9/20250.01 AUD
9/8/20250.01 AUD
9/5/20250.01 AUD
9/4/20250.01 AUD
9/3/20250.01 AUD
9/2/20250.01 AUD
9/1/20250.01 AUD
8/29/20250.01 AUD
8/28/20250.01 AUD
8/27/20250.01 AUD
8/26/20250.01 AUD
8/25/20250.01 AUD
8/22/20250.01 AUD
8/21/20250.01 AUD
8/20/20250.01 AUD
8/19/20250.01 AUD
8/18/20250.01 AUD
8/15/20250.01 AUD
8/14/20250.01 AUD
8/13/20250.01 AUD
8/12/20250.02 AUD
8/11/20250.02 AUD
8/8/20250.02 AUD
8/7/20250.02 AUD
8/6/20250.02 AUD
8/5/20250.02 AUD
8/4/20250.02 AUD
8/1/20250.02 AUD
7/31/20250.02 AUD
7/30/20250.02 AUD
7/29/20250.02 AUD
7/28/20250.02 AUD
7/25/20250.02 AUD
7/24/20250.02 AUD
7/23/20250.02 AUD
7/22/20250.02 AUD
7/21/20250.02 AUD
7/18/20250.02 AUD
7/17/20250.02 AUD
7/16/20250.02 AUD
7/15/20250.02 AUD
7/14/20250.02 AUD
Access this data via the Eulerpool API
Get Free API Key

Acrux Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
3.85 M AUD
-9.49 M AUD
-9.47 M AUD
Jan 1, 2021
4.79 M AUD
-12.80 M AUD
-12.63 M AUD
Jan 1, 2022
5.10 M AUD
-9.58 M AUD
-9.83 M AUD
Jan 1, 2023
11.93 M AUD
109,000.00 AUD
-764,000.00 AUD
Jan 1, 2024
8.10 M AUD
-5.57 M AUD
-5.80 M AUD
Jan 1, 2025
4.53 M AUD
-5.63 M AUD
-5.95 M AUD
Jan 1, 2026 (e)
20.34 M AUD
10.37 M AUD
12.77 M AUD
Jan 1, 2027 (e)
15.00 M AUD
5.18 M AUD
6.33 M AUD

Acrux Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 12, 2026, 3:52 PM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
NET INCOMEM AUD
NET INCOME GROWTH%
DIV.AUD
DIV. GROWTH%
SHARESM
201220132014201520162017201820192020202120222023202420252026e2027e
10.0016.0053.0025.0028.0023.003.005.003.004.005.0011.008.004.0020.0015.00
-89.2560.00231.25-52.8312.00-17.86-86.9666.67-40.0033.3325.00120.00-27.27-50.00400.00-25.00
100.00100.0098.1196.0096.43100.00100.00100.00133.33100.0080.00100.0050.00100.00100.00100.00
10.0016.0052.0024.0027.0023.003.005.004.004.004.0011.004.004.0020.0015.00
7.006.0027.0011.0012.00–-14.00-8.00-9.00-12.00-9.00–-5.00-5.0012.006.00
-87.72-14.29350.00-59.269.09––-42.8612.5033.33-25.00–––-340.00-50.00
0.080.160.230.230.17–––––––––0.170.17
–100.0043.75–-26.09–––––––––––
166.51166.51166.52166.52166.52166.52166.52166.58167.77219.73283.88286.46289.50352.16352.16352.16
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Acrux generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Acrux retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Acrux's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Acrux has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Acrux's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Acrux stock margins

The Acrux margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Acrux. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Acrux.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
100.00 %
-246.68 %
-246.32 %
Jan 1, 2021
100.00 %
-267.03 %
-263.54 %
Jan 1, 2022
100.00 %
-187.77 %
-192.71 %
Jan 1, 2023
95.32 %
0.91 %
-6.41 %
Jan 1, 2024
51.14 %
-68.76 %
-71.62 %
Jan 1, 2025
100.00 %
-124.40 %
-131.29 %
Jan 1, 2026 (e)
100.00 %
50.99 %
62.78 %
Jan 1, 2027 (e)
100.00 %
34.51 %
42.20 %

Acrux Stock Revenue, EBIT, Earnings per Share

The Acrux earnings per share therefore indicates how much revenue Acrux has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.02 AUD
-0.06 AUD
-0.06 AUD
Jan 1, 2021
0.02 AUD
-0.06 AUD
-0.06 AUD
Jan 1, 2022
0.02 AUD
-0.03 AUD
-0.03 AUD
Jan 1, 2023
0.04 AUD
0.00 AUD
-0.00 AUD
Jan 1, 2024
0.03 AUD
-0.02 AUD
-0.02 AUD
Jan 1, 2025
0.01 AUD
-0.02 AUD
-0.02 AUD
Jan 1, 2026 (e)
0.06 AUD
0.03 AUD
0.04 AUD
Jan 1, 2027 (e)
0.04 AUD
0.01 AUD
0.02 AUD

Acrux business model & stock analysis

Acrux Ltd is an Australian pharmaceutical company specializing in the development and marketing of products in the dermatology field. The company was founded in 1998 and is headquartered in Melbourne. Its history begins with the development of a groundbreaking technology called the "Sprayform® Technology," which allows the administration of liquid medications in spray form, providing numerous advantages compared to traditional administration methods. Acrux obtained the first patent for this technology in 1999 and worked on bringing it to the market. Its business model focuses on licensing its Sprayform® Technology to third parties to advance the development and marketing of products in various therapeutic areas. The company has an experienced research and development team that collaborates closely with partners to develop tailored solutions and support the entire development process, ensuring that all products meet the highest quality standards and regulatory requirements. Acrux Ltd is divided into various divisions, including products for women, diabetes, pain and inflammation, as well as neurology and psychiatry. With its Sprayform® Technology, the company has developed unique therapeutic solutions that meet patients' needs. For example, a testosterone preparation for women has been developed that is simply applied as a spray and offers higher efficacy than traditional tablets. Another product is a fast-acting pain reliever that is administered through a nasal spray. Acrux Ltd also has partnerships with major pharmaceutical companies such as Eli Lilly, Johnson & Johnson, Pfizer, and Sanofi. These partnerships enable Acrux to market its technology globally and offer its customers a comprehensive portfolio of tailored solutions. The partner is granted exclusive rights to use the technology for specific products and markets, facilitating the development of new products and the expansion into new regions. Overall, Acrux Ltd has achieved a leadership position in the field of transdermal systems and transmucosal technologies through its innovative Sprayform® Technology. The company aims to further expand its leadership position by focusing on the development of new products and collaboration with partners. Acrux remains in constant exchange with the scientific community to incorporate the latest research and development insights into its products.

Acrux SWOT Analysis

Strengths

Acrux Ltd possesses several strengths that contribute to its success in the market:

  • Strong brand reputation in the industry
  • Robust and innovative product portfolio
  • Well-established distribution network
  • Experienced and skilled workforce
  • Efficient operational processes

Despite its strengths, Acrux Ltd also faces certain weaknesses that need to be addressed:

  • Dependence on key suppliers
  • Limited international market presence
  • Relatively high production costs
  • Inadequate online presence compared to competitors
  • Lack of diversification in product range

Acrux Ltd can capitalize on the following opportunities to expand its market share:

  • Emerging untapped markets with high growth potential
  • Increasing demand for eco-friendly and sustainable products
  • Partnerships and collaborations with other industry leaders
  • Advancements in technology for product development
  • Expansion into online retail channels

Acrux Ltd should be cautious of the following threats in the market:

  • Intense competition from existing and new players
  • Economic downturn and fluctuations in market conditions
  • Changing consumer preferences and trends
  • Potential disruptions in supply chain
  • Regulatory changes impacting the industry

Weaknesses

Despite its strengths, Acrux Ltd also faces certain weaknesses that need to be addressed:

  • Dependence on key suppliers
  • Limited international market presence
  • Relatively high production costs
  • Inadequate online presence compared to competitors
  • Lack of diversification in product range

Acrux Ltd can capitalize on the following opportunities to expand its market share:

  • Emerging untapped markets with high growth potential
  • Increasing demand for eco-friendly and sustainable products
  • Partnerships and collaborations with other industry leaders
  • Advancements in technology for product development
  • Expansion into online retail channels

Acrux Ltd should be cautious of the following threats in the market:

  • Intense competition from existing and new players
  • Economic downturn and fluctuations in market conditions
  • Changing consumer preferences and trends
  • Potential disruptions in supply chain
  • Regulatory changes impacting the industry

Opportunities

Acrux Ltd can capitalize on the following opportunities to expand its market share:

  • Emerging untapped markets with high growth potential
  • Increasing demand for eco-friendly and sustainable products
  • Partnerships and collaborations with other industry leaders
  • Advancements in technology for product development
  • Expansion into online retail channels

Acrux Ltd should be cautious of the following threats in the market:

  • Intense competition from existing and new players
  • Economic downturn and fluctuations in market conditions
  • Changing consumer preferences and trends
  • Potential disruptions in supply chain
  • Regulatory changes impacting the industry

Threats

Acrux Ltd should be cautious of the following threats in the market:

  • Intense competition from existing and new players
  • Economic downturn and fluctuations in market conditions
  • Changing consumer preferences and trends
  • Potential disruptions in supply chain
  • Regulatory changes impacting the industry

Acrux Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Acrux historical P/E ratio, EBIT multiple, and P/S ratio

Acrux annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Acrux shares outstanding

The number of shares of Acrux was 352.16 M in 2025. This indicates how many shares Acrux is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
167.77 M Stocks
Jan 1, 2021
219.73 M Stocks
Jan 1, 2022
283.88 M Stocks
Jan 1, 2023
286.46 M Stocks
Jan 1, 2024
289.50 M Stocks
Jan 1, 2025
352.16 M Stocks
Jan 1, 2026 (e)
352.16 M Stocks
Jan 1, 2027 (e)
352.16 M Stocks

Acrux Dividend History

6 years of dividend payments

YearAnnual DividendYoY ChangePayments
20160.09AUD 0.0%—
20150.09AUD↓ 63.4%1×
20140.23AUD↑ 192.9%2×
20130.08AUD 0.0%1×
20120.08AUD↓ 86.7%1×
20110.60AUD—1×

Acrux dividend payout ratio

In 2025, Acrux had a payout ratio of 143.50%. The payout ratio indicates the percentage of the company's profits that Acrux distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
142.55 %
Jan 1, 2021
143.24 %
Jan 1, 2022
143.85 %
Jan 1, 2023
143.21 %
Jan 1, 2024
143.43 %
Jan 1, 2025
143.50 %
Jan 1, 2026 (e)
472.79 %
Jan 1, 2027 (e)
953.55 %
Price targets and forecasts for Acrux are not yet available.

EESG©

Eulerpool ESG Scorecard© for the Acrux stock

48/100
54
Environment
34
Social
57
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees50
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Acrux shareholder structure

% Name
10.66610%
Phillip Asset Management Limited
Phillip Asset Management Limited
3.40757%
Hishenk Pty. Ltd.
Hishenk Pty. Ltd.
2.81125%
The Poole Family Superannuation Fund Pty. Ltd.
The Poole Family Superannuation Fund Pty. Ltd.
2.34315%
Netwealth Investments Ltd.
Netwealth Investments Ltd.
2.21751%
Chai (Vui Chung Thomas)
Chai (Vui Chung Thomas)
2.09444%
Brumley (Donald Charles)
Brumley (Donald Charles)

Acrux Executives and Management Board

MK

Mr. Michael Kotsanis

Chief Executive Officer, Managing Director, Executive Director · since 2014

Compensation701,959.00 AUD
JJ

Ms. Joanna Johnson

Chief Financial Officer, Company Secretary

Compensation298,616.00 AUD
FC

Ms. Felicia Colagrande

Product Development and Technical Affairs Director

Compensation295,971.00 AUD
MH

Mr. Mark Hyman

Project and Technical Development Director

Compensation285,109.00 AUD
RD

Mr. Ross Dobinson

Independent Non-Executive Chairman of the Board · since 1998

Compensation131,114.00 AUD

Acrux Supply Chain

Acrux Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
3 companies
#Name1M3M6M1Y2YTrend
1
Perrigo
Supplier
-0.69
0.29
0.39
0.80
0.59
#Name1M3M6M1Y2YTrend
1
IQVIA Holdings
Supplier
0.72
0.59
0.68
0.55
-0.66
2
Elanco Animal Health
Supplier
0.38
0.81
0.67
0.89
0.27

Frequently asked questions about Acrux

The business model of Acrux Ltd is focused on pharmaceutical research and development, specifically in the area of innovative transdermal drug delivery. Through its proprietary technology, Acrux has developed unique skin delivery solutions that enable the efficient delivery of a wide range of medications. With a strong emphasis on research and collaboration, Acrux aims to partner with pharmaceutical companies to develop and commercialize new transdermal products. This approach allows Acrux to generate revenue through licensing agreements and royalties, leveraging its expertise in the development and delivery of innovative drug treatments.

All fundamentals and in-depth analysis of Acrux

Our stock analysis for Acrux stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acrux. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Acrux Stock
Acrux Revenue→
Acrux Stock
Acrux Net Income→
Acrux Stock
Acrux P/E→
Acrux Stock
Acrux P/S→
Acrux Stock
Acrux EBIT→
Acrux Stock
Acrux Dividend→
Acrux Stock
Acrux Directors Dealings→
Acrux Stock
Acrux Stocks→
Acrux Stock
Acrux Market capitalization→
Acrux Stock
Acrux Debt→
Acrux Stock
Acrux Liabilities→
Acrux Stock
Acrux Equity→
Acrux Stock
Acrux AAQS→
Acrux Stock
Acrux Employees→
Acrux Stock
Acrux ROE→
Acrux Stock
Acrux ROA→
Acrux Stock
Acrux ROCE→
Acrux Stock
Acrux News→
Acrux Stock
Acrux Analyst Price Targets→

Health Stocks

Actavia Life SciencesAcrobiosystems CoActinium PharmaceuticalsACRO Biomedical CoActinogen MedicalACRO Biomedical CoActive Biotech AB publAcrivon TherapeuticsActuate TherapeuticsAcousortAcuCortAcotec Scientific HoldingsAll Stocks A–Z →